Servier UK
Oscar K. is an experienced Medical Science Liaison specializing in oncology, currently employed at Servier UK since December 2023, after serving in a similar role at Advanced Accelerator Applications, where focus was on radioligand therapy. Prior to this, Oscar worked as a Primary Care Specialist with Star OUTiCO, managing key accounts in the cardiovascular sector. Oscar has also contributed to COVID-19 testing efforts at Sodexo and engaged the public in science communication through roles with Pint of Science UK and as a speaker at various events. With a PhD in Biomedical Engineering from the University of Leeds, Oscar has a strong research background, including developing a medical device for compartment syndrome at Clinical Technologies Ltd. and maintaining ongoing professional development through studies offered by The Royal Society.
This person is not in any teams
This person is not in any offices
Servier UK
1 followers
Servier is an international pharmaceutical company governed by a non-profit foundation with its headquarters in Suresnes (France). With a strong international presence in 149 countries and a turnover of 4.615 billion euros in 2019, Servier employs 22,000 people worldwide. Corporate growth is driven by Servier's constant search for innovation in five areas of excellence: cardiovascular diseases, diabetes, cancers, immune-inflammatory diseases, and neurodegenerative diseases, as well as by its activities in high-quality generic drugs. Being completely independent, the Group reinvests 25% of turnover (excluding generics) in research and development and uses all its profits for growth. Servier was created in 1954, and in 1964 Servier UK was the first subsidiary to open, with just two employees. To report a side effect with one of our products, please visit https://www.servier.co.uk/report-a-side-effect/ Reporting forms and information can also be found at www.mhra.gov.uk/yellowcard